AZN vs RJF · P/E 28, $288.38B cap vs rev $15.91B
AstraZeneca PLC (AZN) versus RJF (RJF) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
RJF (RJF) common stock.
AZN does not have a complete income-statement cache yet.
Latest reported RJF revenue for 2025-09-30 was $15.91B. Net income was $2.13B. Revenue was up 6.6% from 2024-09-30 to 2025-09-30. RJF currently screens at market cap $0.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. RJF currently screens at market cap $0.
Not investment advice. Open the AZN and RJF stock pages for the full models.
Not investment advice.